Back to Journals » Drug Design, Development and Therapy
Drug Design, Development and Therapy
ISSN: 1177-8881
- View all (4135)
- Volume 18, 2024 (96)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Journal Articles:
- Beyond Brain Boundaries: Overcoming the Blood-Brain Barrier to Reach the Central Nervous System (1)
- Using Innovative Drug Delivery Systems to Improve the Efficacy and Applicability of Poorly Water-soluble Drugs (1)
- Advances in design and development of ophthalmic drugs (5)
- A cross-sectional survey on heart failure from China: disease burden and management (3)
- Ten Years of Biosimilars in Europe (4)
Development and Characterization of a Novel Carbon-11 Labeled Positron Emission Tomography Radiotracer for Neuroimaging of Sirtuin 1 with Benzoxazine-Based Compounds
Wang Y, Liu Y, Wang Y, Bai P, Hallisey MR, Varela BL, Siewko A, Wang C, Xu Y
Drug Design, Development and Therapy 2024, 18:819-827
Published Date: 15 March 2024
A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles
Amekyeh H, Sabra R, Billa N
Drug Design, Development and Therapy 2024, 18:613-630
Published Date: 29 February 2024
Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?
Chatzimichail E, Pfau K, Gatzioufas Z, Panos GD
Drug Design, Development and Therapy 2024, 18:365-374
Published Date: 8 February 2024
The Role of Rho Kinase Inhibitors in Corneal Diseases
Futterknecht S, Chatzimichail E, Gugleta K, Panos GD, Gatzioufas Z
Drug Design, Development and Therapy 2024, 18:97-108
Published Date: 19 January 2024
Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies
Panos GD, Lakshmanan A, Dadoukis P, Ripa M, Motta L, Amoaku WM
Drug Design, Development and Therapy 2023, 17:2861-2873
Published Date: 18 September 2023
Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies
Mushtaq Y, Mushtaq MM, Gatzioufas Z, Ripa M, Motta L, Panos GD
Drug Design, Development and Therapy 2023, 17:961-975
Published Date: 30 March 2023
Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies
Karasavvidou EM, Tranos P, Panos GD
Drug Design, Development and Therapy 2022, 16:2659-2680
Published Date: 9 August 2022
Care pathways and treatment patterns for patients with heart failure in China: results from a cross-sectional survey
Jackson JDS, Cotton SE, Bruce Wirta S, Proenca CC, Zhang M, Lahoz R, Balas B, Calado FJ
Drug Design, Development and Therapy 2018, 12:2311-2321
Published Date: 26 July 2018
Burden of heart failure on patients from China: results from a cross-sectional survey
Jackson JDS, Cotton SE, Bruce Wirta S, Proenca CC, Zhang M, Lahoz R, Calado FJ
Drug Design, Development and Therapy 2018, 12:1659-1668
Published Date: 8 June 2018
Burden of heart failure on caregivers in China: results from a cross-sectional survey
Jackson JDS, Cotton SE, Bruce Wirta S, Proenca CC, Zhang M, Lahoz R, Calado FJ
Drug Design, Development and Therapy 2018, 12:1669-1678
Published Date: 8 June 2018
Ten years of biosimilar recombinant human growth hormone in Europe
Saenger P
Drug Design, Development and Therapy 2017, 11:1505-1507
Published Date: 16 May 2017
Ten years of biosimilars in Europe: development and evolution of the regulatory pathways
Schiestl M, Zabransky M, Sörgel F
Drug Design, Development and Therapy 2017, 11:1509-1515
Published Date: 16 May 2017
Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy data
López-Siguero JP, Pfäffle R, Chanson P, Szalecki M, Höbel N, Zabransky M
Drug Design, Development and Therapy 2017, 11:1489-1495
Published Date: 16 May 2017
Ten years of clinical experience with biosimilar human growth hormone: a review of safety data
Borrás Pérez MV, Kriström B, Romer T, Walczak M, Höbel N, Zabransky M
Drug Design, Development and Therapy 2017, 11:1497-1503
Published Date: 16 May 2017